Enliven Therapeutics, Inc. Common Stock (ELVN) is a publicly traded Healthcare sector company. As of May 20, 2026, ELVN trades at $41.87 with a market cap of $2.41B and a P/E ratio of -22.91. ELVN moved +4.27% today. Year to date, ELVN is +175.21%; over the trailing twelve months it is +140.85%. Its 52-week range spans $13.30 to $48.53. Analyst consensus is strong buy with an average price target of $57.14. Rallies surfaces ELVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Enliven Therapeutics, Inc. Common Stock (ELVN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ELVN moved +4.27% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $41.87 |
| Market Cap | $2.41B |
| P/E Ratio | -22.91 |
| EPS | $-1.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $48.53 |
| 52-Week Low | $13.30 |
| Volume | 567.19K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-103.69M |
| Gross Margin | 0.00% |
8 analysts cover ELVN: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $57.14.